These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31602654)
1. Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma. Wu G; Zhang Z; Tang Q; Liu L; Liu W; Li Q; Wang Q J Cell Physiol; 2020 Apr; 235(4):3776-3789. PubMed ID: 31602654 [TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma. Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117 [TBL] [Abstract][Full Text] [Related]
3. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma. Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402 [TBL] [Abstract][Full Text] [Related]
4. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway. Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158 [TBL] [Abstract][Full Text] [Related]
5. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma. Tölle A; Suhail S; Jung M; Jung K; Stephan C BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the roles of fatty acid transport related proteins in clear cell renal cell carcinoma. Zheng J; Li YZ; Ni WJ; Hou SM; Lu KQ; Yan Y; Ren LQ; Liu BC; Wang B Prostaglandins Other Lipid Mediat; 2023 Aug; 167():106732. PubMed ID: 37044156 [TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
9. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis. Wang S; Yu ZH; Chai KQ Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834 [TBL] [Abstract][Full Text] [Related]
11. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose. Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J Islets; 2010; 2(3):174-84. PubMed ID: 21099311 [TBL] [Abstract][Full Text] [Related]
12. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway. Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma. Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328 [TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694 [TBL] [Abstract][Full Text] [Related]
15. Role of fatty acid binding proteins (FABPs) in cancer development and progression. McKillop IH; Girardi CA; Thompson KJ Cell Signal; 2019 Oct; 62():109336. PubMed ID: 31170472 [TBL] [Abstract][Full Text] [Related]
16. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma. Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma. Huang JL; Liao Y; Qiu MX; Li J; An Y Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366 [TBL] [Abstract][Full Text] [Related]
19. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma. Zheng J; Wang L; Peng Z; Yang Y; Feng D; He J EBioMedicine; 2017 Feb; 15():62-72. PubMed ID: 27993630 [TBL] [Abstract][Full Text] [Related]
20. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data. Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]